Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia in an Elderly Population
Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia in an Elderly Population: an Open-label Study
Sponsor: Banner Health
Terminated
Lack of subjects
Other terminated trials from Banner Health
Other Fibromyalgia trials with similar outcome
Listed as NCT01418651, this PHASE3 trial focuses on Fibromyalgia and remains terminated or withdrawn. Sponsored by Banner Health, it has been updated 6 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE3
First recorded
Mar 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Banner Health
- Forest Laboratories
For direct contact, visit the study record on ClinicalTrials.gov .